{"data":[{"accessionNo":"0001231919-26-000927","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":11530414,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001231919-26-000927","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":11530414,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001231919-26-000927","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":11530414,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001231919-26-000927","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-06-30","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":11530414,"percentOfClass":9.9,"filedAt":"2026-08-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002100119-26-001443","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings Inc","ticker":"RANI","cusip":"753018100","securityClass":"Common Stock","eventDate":"2026-06-30","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":5052862,"percentOfClass":4.49,"filedAt":"2026-07-31","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-05-26","reportingPerson":"Srinivas Akkaraju","reportingCik":"0001253170","personType":"IN","sharesOwned":11322961,"percentOfClass":9.9,"filedAt":"2026-05-28","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-05-26","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":"0001888829","personType":"OO","sharesOwned":5661481,"percentOfClass":5,"filedAt":"2026-05-28","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-05-26","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":"0002086193","personType":"PN","sharesOwned":5661480,"percentOfClass":5,"filedAt":"2026-05-28","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-05-26","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":"0002086456","personType":"OO","sharesOwned":5661480,"percentOfClass":5,"filedAt":"2026-05-28","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-26-000014","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":"753018100","securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2026-05-26","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":"0001699737","personType":"PN","sharesOwned":5661481,"percentOfClass":5,"filedAt":"2026-05-28","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002006045-26-000008","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":"075301810","securityClass":"Class A Common Stock","eventDate":"2026-03-27","reportingPerson":"SymBiosis Capital Partners, LLC","reportingCik":null,"personType":"IA","sharesOwned":4433620,"percentOfClass":4.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002100119-26-000988","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings Inc","ticker":"RANI","cusip":"753018100","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Vanguard Capital Management","reportingCik":null,"personType":"IA","sharesOwned":5109368,"percentOfClass":5.12,"filedAt":"2026-04-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0000102909-26-002113","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings Inc","ticker":"RANI","cusip":"753018100","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001535264-26-000007","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, Par Value $.0001","eventDate":"2025-12-31","reportingPerson":"AWM Investment Company, Inc.","reportingCik":null,"personType":"IA","sharesOwned":9745343,"percentOfClass":9.9,"filedAt":"2026-02-13","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002006045-26-000003","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock","eventDate":"2025-11-13","reportingPerson":"SymBiosis Capital Partners, LLC","reportingCik":null,"personType":"IA","sharesOwned":6300000,"percentOfClass":6.5,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0000102909-26-000264","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings Inc","ticker":"RANI","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":5109368,"percentOfClass":5.23,"filedAt":"2026-01-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001172661-25-005149","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Armistice Capital, LLC","reportingCik":null,"personType":"IA,OO","sharesOwned":2515652,"percentOfClass":4.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001172661-25-005149","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Steven Boyd","reportingCik":null,"personType":"HC,IN","sharesOwned":2515652,"percentOfClass":4.99,"filedAt":"2025-11-14","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-25-000014","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Srinivas Akkaraju","reportingCik":"0001253170","personType":"IN","sharesOwned":9882477,"percentOfClass":9.9,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001346824-25-000031","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Peter Kolchinsky","reportingCik":null,"personType":"HC,IN","sharesOwned":9882477,"percentOfClass":9.9,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001346824-25-000031","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Rajeev Shah","reportingCik":null,"personType":"HC,IN","sharesOwned":9882477,"percentOfClass":9.9,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001346824-25-000031","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"RA Capital Healthcare Fund, L.P.","reportingCik":null,"personType":"PN","sharesOwned":9882477,"percentOfClass":9.9,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001346824-25-000031","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"RA Capital Management, L.P.","reportingCik":null,"personType":"IA,PN","sharesOwned":9882477,"percentOfClass":9.9,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-25-000014","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Samsara BioCapital GP, LLC","reportingCik":"0001888829","personType":"OO","sharesOwned":4941239,"percentOfClass":5,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-25-000014","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Samsara BioCapital, L.P.","reportingCik":"0001699737","personType":"PN","sharesOwned":4941239,"percentOfClass":5,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-25-000014","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Samsara Opportunity Fund, L.P.","reportingCik":"0002086193","personType":"PN","sharesOwned":4941238,"percentOfClass":5,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001699737-25-000014","formType":"SCHEDULE 13D","amendmentNo":null,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value per share","eventDate":"2025-10-23","reportingPerson":"Samsara Opportunity Fund GP, LLC","reportingCik":"0002086456","personType":"OO","sharesOwned":4941238,"percentOfClass":5,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001873082-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-23","reportingPerson":"MIR A IMRAN","reportingCik":"0001031686","personType":"IN","sharesOwned":27093552,"percentOfClass":22.1,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001873082-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-23","reportingPerson":"InCube Labs, L.L.C.","reportingCik":"0001873082","personType":"CO","sharesOwned":22424788,"percentOfClass":18.7,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001873082-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-23","reportingPerson":"InCube Ventures II, LP","reportingCik":null,"personType":"PN","sharesOwned":301710,"percentOfClass":0.3,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001873082-25-000003","formType":"SCHEDULE 13D/A","amendmentNo":1,"issuerCik":"0001856725","issuerName":"RANI THERAPEUTICS HOLDINGS, INC.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-23","reportingPerson":"Rani Investment Corp.","reportingCik":null,"personType":"CO","sharesOwned":7694,"percentOfClass":0,"filedAt":"2025-10-27","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Raymond Debbane","reportingCik":null,"personType":"IN","sharesOwned":9825911,"percentOfClass":9.99,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Invus Global Management, LLC","reportingCik":null,"personType":"OO","sharesOwned":8617378,"percentOfClass":8.8,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Siren, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":8617378,"percentOfClass":8.8,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Invus Public Equities, L.P.","reportingCik":null,"personType":"PN","sharesOwned":8617378,"percentOfClass":8.8,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Invus Public Equities Advisors, LLC","reportingCik":null,"personType":"OO","sharesOwned":8617378,"percentOfClass":8.8,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Avicenna Life Sci Master Fund LP","reportingCik":null,"personType":"PN","sharesOwned":1208533,"percentOfClass":1.3,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Avicenna Life Sci Master GP LLC","reportingCik":null,"personType":"OO","sharesOwned":1208533,"percentOfClass":1.3,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0002005369-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, $0.0001 par value","eventDate":"2025-10-16","reportingPerson":"Ulys, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":1208533,"percentOfClass":1.3,"filedAt":"2025-10-23","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001104659-25-101616","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-20","reportingPerson":"South Cone Investments Limited Partnership","reportingCik":"0001876412","personType":"PN","sharesOwned":2379194,"percentOfClass":4.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001104659-25-101616","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-20","reportingPerson":"South Lake One LLC","reportingCik":"0001794292","personType":"OO","sharesOwned":2379194,"percentOfClass":4.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/rani"},{"accessionNo":"0001104659-25-101616","formType":"SCHEDULE 13D/A","amendmentNo":5,"issuerCik":"0001856725","issuerName":"Rani Therapeutics Holdings, Inc.","ticker":"RANI","cusip":null,"securityClass":"Class A Common Stock, par value $0.0001 per share","eventDate":"2025-10-20","reportingPerson":"South Lake Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2379194,"percentOfClass":4.9,"filedAt":"2025-10-22","canonicalUrl":"https://xoomar.com/markets/stocks/rani"}],"updatedAt":"2026-11-05T16:29:24.533Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rani","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}